A new type of weekly injection could make type 2 diabetes treatment easier. Taking weekly injections of a medication called exenatide could help people with diabetes better manage their condition, according to recent reports.
Exenatide is a type 2 diabetes drug that helps people with diabetes to control their blood glucose . Exenatide is usually prescribed to type 2 diabetics, and is not the same thing as insulin . Exenatide is marketed under the brand Byetta.
A recent study conducted by experts at the Mount Sinai Hospital in the University of Toronto, Canada, and the University of North Carolina School of Medicine found that weekly injections were more effective in controlling diabetes . The study, which was published in the Lancet, was published by Amylin Pharmaceuticals and Eli Lilly .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…